¡El sitio web de IMCAS tiene una nueva apariencia! Explore nuestro sitio web rediseñado. Estamos aquí para ayudarle a navegar por las nuevas funciones y agradecemos sus comentarios en contact@imcas.com.
English
Español
Français
Português
Русский
简体中文
NANOPASS TECHNOLOGIES LTD
Israel
Sitio web: https://micronjet.nanopass.com/
Número de stand: K216
Categorías industriales
Perfil de la empresa
NanoPass Technologies Ltd. is a pioneer in intradermal delivery, leveraging its proprietary MicronJet™ platform—the first FDA-cleared true intradermal delivery technology (<1 mm)—to transform treatments across both medical and aesthetic fields. With over 70 clinical studies and millions of successful procedures worldwide, the company is at the forefront of advancing vaccines, immunotherapies, and drug delivery, enabling proven dose-sparing and improved patient outcomes. In parallel, NanoPass has brought its innovation to the aesthetic landscape, where MicronJet™ provides physicians and patients with a new standard of safety, precision, and comfort—minimizing bruising, pain, and downtime while enabling consistent delivery of skin boosters, polynucleotides, PRP, and other intradermal treatments. Today, NanoPass operates globally in more than 30 countries, partnering with leading pharmaceutical and aesthetic brands.
Descubra IMCAS Academy
¿Necesita ayuda?